{"id":"W2140104756","doi":"10.1093/annonc/mdg496","title":"Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group","year":2003,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada); Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Gemcitabine; Neutropenia; Regimen; Internal medicine; Salvage therapy; Dexamethasone; Phases of clinical research; Chemotherapy; Surgery; Transplantation; Progressive disease; Gastroenterology; Chemotherapy regimen; Cisplatin; Refractory (planetary science); Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002102161,0.001069058,0.002529792,0.0008143926,0.0006874596,0.001187479,0.001014414,0.001349229,0.003241138],"category_scores_gemma":[0.001313763,0.0006354655,0.001274098,0.000994612,0.001538452,0.001140607,0.000450822,0.003203857,0.0005261818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001746197,"about_ca_system_score_gemma":0.002439599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005930096,"about_ca_topic_score_gemma":0.02193348,"domain_scores_codex":[0.9993932,0.0003307479,0.00003209284,0.00006657177,0.00006543612,0.0001119884],"domain_scores_gemma":[0.998875,0.0002204406,0.0001624319,0.00008173988,0.0000538685,0.0006065804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8780409,0.03284919,0.005258251,0.0007657075,0.001425408,0.0001174216,0.0002412019,0.001450775,0.005028605,0.0002758666,0.002356142,0.07219059],"study_design_scores_gemma":[0.7788358,0.2064371,0.01037013,0.00005626004,0.0005664643,0.0001072122,0.0000901159,0.0004360597,0.0008300738,0.000155772,0.002090538,0.00002444408],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914542,0.004415005,0.0001602876,0.0004675521,0.0001590538,0.001161119,0.0006068014,0.00002711607,0.001548934],"genre_scores_gemma":[0.9889666,0.005244638,0.0006380706,0.0006767447,0.0001651145,0.0009440556,0.001246186,0.0000178023,0.002100595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005930096,"threshold_uncertainty_score":0.01266956,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.23709605487565,"score_gpt":0.5114015104831595,"score_spread":0.2743054556075095,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}